Skip to content
GLP-1 Decoder

Victoza Reviews: Real Experiences, Sorted by Outcome

Victoza reviews: what people report, grouped by theme, next to what the trials found.

Active ingredient
liraglutide
Manufacturer
Novo Nordisk
How it is taken
Daily injection
FDA-approved for
Type 2 diabetes, Heart risk
Victoza reviews: a notebook and a weekly GLP-1 pen on a kitchen table

Victoza: key facts

Time it remains in your body
100%50%25%0%013 h26 h39 h2.2 d2.7 d50%25%12.5%time after the dose

Its half-life is about 13 hours. After 13 h, half is gone, and about 3% remains after five half-lives (2.7 d).

Weight lost in its main trial
Victoza (LEAD-3)2.5 kgPlacebo1.1 kg

In LEAD-3, people with type 2 diabetes lost 2.5 kg over 52 weeks, compared with 1.1 kg on placebo.

Sources: FDA label (DailyMed).